Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

I've asked you and others the question I wanted to ask. Why not try to explain?

Why do you suppose that the Company chose to limit the distribution of the news that Brilacidin has a feature that "distinguishes it from all other known anti-SARS-CoV-2 drug candidates in development" to a Shareholder Alert?

Assuming that Brilacidin has such a feature I would expect this CEO to be shouting it from a rooftop, wouldn't you?

If the question truly raises doubt as to the veracity of what was communicated in the shareholder alert all the more reason to answer it. At least TRY.